Pediatric-onset mastocytosis: A long term clinical follow-up and correlation with bone marrow histopathology

Ashraf Uzzaman, Irina Maric, Pierre Noel, Brett V. Kettelhut, Dean D. Metcalfe, Melody C. Carter

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Background. Pediatric onset mastocytosis usually presents as urticaria pigmentosa; and less often as diffuse cutaneous mastocytosis. While the literature indicates that disease often resolves, there has been a move to more aggressive therapy for mastocytosis early in life. We addressed the long term prognosis of pediatric-onset disease by examining 17 children with mastocytosis which we had reported on in 1989 [1]. Procedure. We successfully contacted 15 of these patients and data was collected regarding their clinical status. Original bone marrow specimens were re-stained, reexamined, and correlated with disease outcome using consensus criteria. Three of five patients with persistent disease underwent repeat bone marrow biopsies. Results. There was complete regression of disease as defined by cutaneous findings and symptoms (clinical disease severity) in 10 of 15 patients (67%). Three patients had major (20%) and two had partial regression of disease (13%). Repeat marrow examinations on three patients with persistent disease documented systemic mastocytosis based on marrow findings in one patient who had partial regression of disease and was the only patient with initial morphologic evidence of systemic disease. Of the remaining two patients, one demonstrated partial regression and the other major regression of disease; and neither had evidence of systemic mastocytosis. Conclusion. This study demonstrates that initial bone marrow biopsies were prognostic in that those without evidence of systemic disease experienced disease regression; and that the long term prognosis for children managed symptomatically with mastocytosis is highly encouraging.

Original languageEnglish (US)
Pages (from-to)629-634
Number of pages6
JournalPediatric Blood and Cancer
Volume53
Issue number4
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Mastocytosis
Bone Marrow
Pediatrics
Systemic Mastocytosis
Cutaneous Mastocytosis
Urticaria Pigmentosa
Biopsy

Keywords

  • Bone marrow
  • Cutaneous mastocytosis
  • KIT
  • Pediatric mastocytosis
  • Serum tryptase
  • Urticaria pigmentosa

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Medicine(all)

Cite this

Uzzaman, A., Maric, I., Noel, P., Kettelhut, B. V., Metcalfe, D. D., & Carter, M. C. (2009). Pediatric-onset mastocytosis: A long term clinical follow-up and correlation with bone marrow histopathology. Pediatric Blood and Cancer, 53(4), 629-634. https://doi.org/10.1002/pbc.22125

Pediatric-onset mastocytosis : A long term clinical follow-up and correlation with bone marrow histopathology. / Uzzaman, Ashraf; Maric, Irina; Noel, Pierre; Kettelhut, Brett V.; Metcalfe, Dean D.; Carter, Melody C.

In: Pediatric Blood and Cancer, Vol. 53, No. 4, 10.2009, p. 629-634.

Research output: Contribution to journalArticle

Uzzaman, A, Maric, I, Noel, P, Kettelhut, BV, Metcalfe, DD & Carter, MC 2009, 'Pediatric-onset mastocytosis: A long term clinical follow-up and correlation with bone marrow histopathology', Pediatric Blood and Cancer, vol. 53, no. 4, pp. 629-634. https://doi.org/10.1002/pbc.22125
Uzzaman, Ashraf ; Maric, Irina ; Noel, Pierre ; Kettelhut, Brett V. ; Metcalfe, Dean D. ; Carter, Melody C. / Pediatric-onset mastocytosis : A long term clinical follow-up and correlation with bone marrow histopathology. In: Pediatric Blood and Cancer. 2009 ; Vol. 53, No. 4. pp. 629-634.
@article{3801a03720614ceda1a0c2722ddc05ef,
title = "Pediatric-onset mastocytosis: A long term clinical follow-up and correlation with bone marrow histopathology",
abstract = "Background. Pediatric onset mastocytosis usually presents as urticaria pigmentosa; and less often as diffuse cutaneous mastocytosis. While the literature indicates that disease often resolves, there has been a move to more aggressive therapy for mastocytosis early in life. We addressed the long term prognosis of pediatric-onset disease by examining 17 children with mastocytosis which we had reported on in 1989 [1]. Procedure. We successfully contacted 15 of these patients and data was collected regarding their clinical status. Original bone marrow specimens were re-stained, reexamined, and correlated with disease outcome using consensus criteria. Three of five patients with persistent disease underwent repeat bone marrow biopsies. Results. There was complete regression of disease as defined by cutaneous findings and symptoms (clinical disease severity) in 10 of 15 patients (67{\%}). Three patients had major (20{\%}) and two had partial regression of disease (13{\%}). Repeat marrow examinations on three patients with persistent disease documented systemic mastocytosis based on marrow findings in one patient who had partial regression of disease and was the only patient with initial morphologic evidence of systemic disease. Of the remaining two patients, one demonstrated partial regression and the other major regression of disease; and neither had evidence of systemic mastocytosis. Conclusion. This study demonstrates that initial bone marrow biopsies were prognostic in that those without evidence of systemic disease experienced disease regression; and that the long term prognosis for children managed symptomatically with mastocytosis is highly encouraging.",
keywords = "Bone marrow, Cutaneous mastocytosis, KIT, Pediatric mastocytosis, Serum tryptase, Urticaria pigmentosa",
author = "Ashraf Uzzaman and Irina Maric and Pierre Noel and Kettelhut, {Brett V.} and Metcalfe, {Dean D.} and Carter, {Melody C.}",
year = "2009",
month = "10",
doi = "10.1002/pbc.22125",
language = "English (US)",
volume = "53",
pages = "629--634",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Pediatric-onset mastocytosis

T2 - A long term clinical follow-up and correlation with bone marrow histopathology

AU - Uzzaman, Ashraf

AU - Maric, Irina

AU - Noel, Pierre

AU - Kettelhut, Brett V.

AU - Metcalfe, Dean D.

AU - Carter, Melody C.

PY - 2009/10

Y1 - 2009/10

N2 - Background. Pediatric onset mastocytosis usually presents as urticaria pigmentosa; and less often as diffuse cutaneous mastocytosis. While the literature indicates that disease often resolves, there has been a move to more aggressive therapy for mastocytosis early in life. We addressed the long term prognosis of pediatric-onset disease by examining 17 children with mastocytosis which we had reported on in 1989 [1]. Procedure. We successfully contacted 15 of these patients and data was collected regarding their clinical status. Original bone marrow specimens were re-stained, reexamined, and correlated with disease outcome using consensus criteria. Three of five patients with persistent disease underwent repeat bone marrow biopsies. Results. There was complete regression of disease as defined by cutaneous findings and symptoms (clinical disease severity) in 10 of 15 patients (67%). Three patients had major (20%) and two had partial regression of disease (13%). Repeat marrow examinations on three patients with persistent disease documented systemic mastocytosis based on marrow findings in one patient who had partial regression of disease and was the only patient with initial morphologic evidence of systemic disease. Of the remaining two patients, one demonstrated partial regression and the other major regression of disease; and neither had evidence of systemic mastocytosis. Conclusion. This study demonstrates that initial bone marrow biopsies were prognostic in that those without evidence of systemic disease experienced disease regression; and that the long term prognosis for children managed symptomatically with mastocytosis is highly encouraging.

AB - Background. Pediatric onset mastocytosis usually presents as urticaria pigmentosa; and less often as diffuse cutaneous mastocytosis. While the literature indicates that disease often resolves, there has been a move to more aggressive therapy for mastocytosis early in life. We addressed the long term prognosis of pediatric-onset disease by examining 17 children with mastocytosis which we had reported on in 1989 [1]. Procedure. We successfully contacted 15 of these patients and data was collected regarding their clinical status. Original bone marrow specimens were re-stained, reexamined, and correlated with disease outcome using consensus criteria. Three of five patients with persistent disease underwent repeat bone marrow biopsies. Results. There was complete regression of disease as defined by cutaneous findings and symptoms (clinical disease severity) in 10 of 15 patients (67%). Three patients had major (20%) and two had partial regression of disease (13%). Repeat marrow examinations on three patients with persistent disease documented systemic mastocytosis based on marrow findings in one patient who had partial regression of disease and was the only patient with initial morphologic evidence of systemic disease. Of the remaining two patients, one demonstrated partial regression and the other major regression of disease; and neither had evidence of systemic mastocytosis. Conclusion. This study demonstrates that initial bone marrow biopsies were prognostic in that those without evidence of systemic disease experienced disease regression; and that the long term prognosis for children managed symptomatically with mastocytosis is highly encouraging.

KW - Bone marrow

KW - Cutaneous mastocytosis

KW - KIT

KW - Pediatric mastocytosis

KW - Serum tryptase

KW - Urticaria pigmentosa

UR - http://www.scopus.com/inward/record.url?scp=69849091836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69849091836&partnerID=8YFLogxK

U2 - 10.1002/pbc.22125

DO - 10.1002/pbc.22125

M3 - Article

C2 - 19526526

AN - SCOPUS:69849091836

VL - 53

SP - 629

EP - 634

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 4

ER -